SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-074541
Filing Date
2014-10-29
Accepted
2014-10-29 06:00:55
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 20-F a14-23085_120f.htm 20-F 4806697
2 EX-12.01 a14-23085_1ex12d01.htm EX-12.01 12070
3 EX-12.02 a14-23085_1ex12d02.htm EX-12.02 12081
4 EX-13.01 a14-23085_1ex13d01.htm EX-13.01 7202
5 EX-13.02 a14-23085_1ex13d02.htm EX-13.02 7213
6 EX-23.01 a14-23085_1ex23d01.htm EX-23.01 1990
7 GRAPHIC g230851bwi001.jpg GRAPHIC 17776
8 GRAPHIC g230851dei001.jpg GRAPHIC 14471
9 GRAPHIC g230851bmi001.jpg GRAPHIC 18116
  Complete submission text file 0001104659-14-074541.txt   4918050
Mailing Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065
Business Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065 011613-9415-1135
GENETIC TECHNOLOGIES LTD (Filer) CIK: 0001166272 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 000-51504 | Film No.: 141178490
SIC: 2836 Biological Products, (No Diagnostic Substances)